Leonardo Roever Shares a Study on Eligibility Criteria for Endovascular Thrombectomy
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn:
”Endovascular Thrombectomy for Acute Stroke: Evolving Eligibility Criteria and Adjuvant Therapies
In this review, the authors present recent developments, highlighting how biological targets align with the pathophysiological chronology of primary and secondary injury after an ischemic stroke.
It also discusses why some clinical trials have demonstrated success and others may not, and proposes important considerations for the planning of future trials.
This synthesis aims to inform about the evolving evidence for the treatment of acute ischemic stroke and inspire the planning of clinical trials and next-generation therapies.
See the article.
Follow me for more content on evidence, management, and innovation in healthcare!”
Read the full article here.
Article: Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapies
Authors: Martina Glavan, Jia Liu, Gisele Sampaio Silva, Thanh N Nguyen, Jiangbing Zhou, Nenad Sestan et al.
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 19, 2026, 15:16Irina Pahlevanyan: Global Leaders on Courage, Trust, and the True Purpose of Fundraising
-
Feb 19, 2026, 15:12Stéphanie Forté: Transition Readiness in Youth With Sickle Cell Disease
-
Feb 19, 2026, 15:08Tagreed Alkaltham: Strengthening Blood Inventory Governance Through RFID Technology
-
Feb 19, 2026, 14:59Başak Taburoğlu Yılmaz: Improving Diagnosis and Care for Women With Bleeding Disorders
-
Feb 19, 2026, 14:59Munira Borhany: Moving Beyond Stereotypes in the Diagnosis of Bleeding Disorders
-
Feb 19, 2026, 14:56Flora Peyvandi: Personalized VWF Dosing Revolutionizes Surgery in VWD
-
Feb 19, 2026, 14:54Michela Mazzon: The Molecular Trigger Behind the COVID19 Vaccines-Associated ITT
-
Feb 19, 2026, 14:42Luca Palombi: Real-Time Assessment of Venous Hemodynamics During Movement With DUS
-
Feb 19, 2026, 14:41Cansu Kose: Cardiovascular Disease in Women Requires More Than Male-Derived Frameworks